|
||||||||||||||||||||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||||||||||||||||||||
|
Though it is the leading cancer death of both men and women in the United States, lung cancer research remains grossly under funded. "Three passions, simple but overwhelmingly strong, have governed my life: the longing for love, the search for knowledge, and unbearable pity for the suffering of mankind." |
RESEARCH AND GRANTS Though it is the leading cancer death of both men and women in the United States, lung cancer research remains grossly under funded. The August, 2001 Report of the Lung Cancer Progress Review Group to NCI described research funding for lung cancer as “far below the levels that characterize other common malignancies and far out of proportion to its massive public health impact.“ Estimated data from 2008, seven years after the publication indicates little has changed. Federally funded lung cancer research programs are limited. The National Cancer Institute (NCI) 2008 funding statistics are as follows:
Money for lung cancer research has traditionally come almost exclusively from government sources. Very little money designated for lung cancer research comes from the private sector.
Although the government needs to step up to its responsibility of increasing funding for lung cancer research in proportion to its public health impact, it is also necessary to call on the private sector’s generosity in funding lung cancer research. Therefore, the focus of the LCFA will be to open the door to the private sector money supply to support research leading to effective and safe tools for the prediction, early detection and treatment of lung cancer.
|
|||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||